Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Clinical trial NCT01825122 · COMPLETED
Trial details
- NCT number
- NCT01825122
- Sponsor
- Invion, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.